Skip to main content

EISMEA — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

616
Companies
$2.9B
Total invested
$4.6M
Avg. check
54
Industries
Health Care 9Biotechnology 8Medical 5Pharmaceutical 4Therapeutics 4Manufacturing 3+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 616
HAWK Biosystems
October 2026

HAWK Biosystems is a cancer diagnostics platform.

Biotechnology · Derio$3.9M Venture - Series Unknown
Goodwall
September 2026

Goodwall is a social development platform for young people to connect over shared interests and discover opportunities.

Career Planning · Genève$494K Grant
VitalFluid
August 2026

VitalFluid is a young innovative company specialised in Plasma Activated Water (PAW), engineering & design of PAW-equipment and application.

Organic Food · Veldhoven$20.0M Series A
SweGaN
August 2026

SweGaN provides GaN-on-SiC epiwafers based on ground-breaking epitSaxial growth technology for manufacturers of RF components and devices.

Computer · Linköping$14.0M Series B
FuVeX
August 2026

FuVeX is dedicated to the design, manufacture, and commercialization of drones.

Aerospace · Tudela$3.5M Venture - Series Unknown
RVE.SOL - Solucoes de Energia Rural
July 2026

RVE.SOL creates alternative, renewable energy choices for the rural poor, enabling them to make use of natural resources.

Energy · Leiria$2.0M Grant
Natac
July 2026

Natac is a company dedicated to investigating, developing, and sustainably manufacturing ingredients of natural origin.

Animal Feed · Madrid$1.6M Grant
X1 Wind
July 2026

X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters.

CleanTech · Barcelona$5.1M Seed
Hydromea
June 2026

Automating submerged asset inspections with a remote underwater drone platform

Communications Infrastructure · Renens$1.0M Grant
Dawex
June 2026

Dawex is the leading data exchange technology company and the operator of the largest data marketplace.

Analytics · San FranciscoCorporate Round
Alzinova
June 2026

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Biotechnology · Gothenburg$1.6M Post-IPO Equity
Klaria Pharma Holding
June 2026

Klaria's business concept is to develop and commercialize innovative products

Pharmaceutical · Uppsala$2.6M Post-IPO Debt
ChemoTech
June 2026

ChemoTech is an innovator in gentle cancer treatment and effective pain management.

Health Care · Lund$644K Post-IPO Debt
Ynvisible Interactive
May 2026

Ynvisible is an electronics company that specializes in the internet of things industry.

Consumer Electronics · Vancouver$324K Grant
IRLAB Therapeutics
May 2026

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

Health Care · Göteborg$11.0M Post-IPO Equity
CellPly
April 2026

Developing analytical systems to characterize next-generation cancer immunotherapy

Bioinformatics · Bologna$8.4M Venture - Series Unknown
Exogenus Therapeutics
April 2026

Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.

Biotechnology · CantanhedeGrant
BiBBInstruments
April 2026

BiBBInstruments has develops an instrument that allows quick and easy sampling of suspected cancer tumors by drilling into the tissue.

Health Care · Lund$4.5M Post-IPO Equity
TechNovator
April 2026

TechNovator – wireless power transfer based on quantum mechanical principles.

Energy · KepnoGrant
Peptomyc
March 2026

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

Biotechnology · Barcelona$5.8M Venture - Series Unknown
BioCopy
March 2026

BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier.

Biotechnology · Freiburg$11.3M Series A
LipUm
March 2026

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

Biotechnology · Umeå$9.3M Grant
Barbara
January 2026

Barbara is the Edge AI platform to deploy and manage the lifecycle of AI models across distributed locations.

Artificial Intelligence (AI) · Bilbao$5.2M Venture - Series Unknown
Cardiawave
January 2026

Cardiawave is a medical device company .

Collaboration · Paris$4.2M Equity Crowdfunding

Where EISMEA invests

Health Care9
Biotechnology8
Medical5
Pharmaceutical4
Therapeutics4
Manufacturing3

About EISMEA's portfolio

How many companies has EISMEA invested in?▸

EISMEA has invested in 616 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EISMEA invest in?▸

EISMEA's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 54 different industry categories.

What is EISMEA's largest investment?▸

Among tracked funding rounds, VitalFluid received $20.0M in a Series A round. EISMEA's total known invested capital is $2.9B.

What is the average investment size for EISMEA?▸

EISMEA's average investment size is $4.6M across its portfolio of 616 companies.

What are EISMEA's most recent investments?▸

Recent EISMEA portfolio additions include HAWK Biosystems, Goodwall, VitalFluid, SweGaN, FuVeX. These companies were founded in 2020 or later.

Reach the founders behind these 616 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →